Neyssa Marina
Academic Appointments
- Professor - Med Center Line, Pediatrics - Hematology & Oncology
- Member, Child Health Research Institute
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Pediatric Hematology/Oncology 2516 Stockton Blvd Ticon II Building Sacramento, CA 95817 Tel Work (650) 497-8953 Fax (650) 497-8101Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 723-5535Alternate Contact Annamarie Coelho Administrative Assistant Email Tel Work 650-723-5535Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Soft Tissue Sarcoma
- sarcomas
- Oncology (Cancer), Pediatric
- Hematology/Oncology/Stem Cell Transplant, Pediatric
- Pediatric Hematology-Oncology
Administrative Appointments
- Director, Pediatric Hematology-Oncology Fellowship Program, Stanford University (2000 - 2008)
- Director of Hematology-Oncology Outpatient Clinic, Lucile Packard Children's Hospital (2000 - present)
- Associate Chief of Clinical Affairs, Pediatric Hematology-Oncology, Lucile Packard Children's Hospital (2006 - 2011)
Honors and Awards
- Alfa Omega Alfa Honor Society, Alfa Omega Alfa (1982)
- Phi Kappa Phi Honor Society, Phi Kappa Phi (1979)
- Magna Cum Laude-Antoine Lavoiser Chemistry Award, University of PR, Mayaguez Campus (1979)
Professional Education
| Board Certification: | Pediatric Hematology-Oncology, American Board of Pediatrics (1990) |
| Fellowship: | St. Jude Children's Research Hospital TN (1989) |
| Board Certification: | General Pediatrics, American Board of Pediatrics (1987) |
| Residency: | University Pediatric Hospital, Puerto Rico (1986) |
| Internship: | University Pediatric Hospital, Puerto Rico (1984) |
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
The main focus of my research is the development of new treatment strategies for patients with bone sarcoma.
Clinical Trials
- A Placebo-Controlled Study of AZD0530 in Patients With Recurrent Osteosarcoma Localized to the Lung Recruiting
- AAML08B1: Biology Study of Transient Myeloproliferative Disorder in Children with Down Syndrome Recruiting
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Recruiting
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Recruiting
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor Recruiting
Publications
- Outcome for adolescent and young adult patients with osteosarcoma: A report from the Children's Oncology Group. Cancer. 2012
- Symptom cluster analyses based on symptom occurrence and severity ratings among pediatric oncology patients during myelosuppressive chemotherapy. Cancer Nurs. 2012; (1): 19-28
- An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy. Support Care Cancer. 2011; (3): 353-61
- Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011; (6): 939-42
- High-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone sarcomas. Cancer. 2011; (12): 2822; author reply 2822-3
Help